HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Prevalent serogroups and antimicrobial susceptibility of Shigella strains in Metro Manila, 1982-1988.

AbstractFrom 1982 to 1988, Shigella was detected in 4% of stool specimens cultured at The Research Institute for Tropical Medicine (RITM), Manila. S. flexneri was the most prevalent serogroup with 2a, 1b and 1a as the predominant serotypes. Isolation was most frequent during the July to December period. Drug resistance was most often observed in S. flexneri with serotype 2a exhibiting resistance to the combination of ampicillin, chloramphenicol, tetracycline and streptomycin. More multiple-drug than single-drug resistant strains were observed for the last four years. Ampicillin is still the most frequently used drug for most forms of shigellosis in the Philippines. However, the demonstration of increasing resistance among the isolates studied in RITM underscores the need to monitor antibiotic susceptibility studies and document the emergence of resistant strains in the entire country.
AuthorsF T Leaño, M C Saniel, O T Monzon (Affiliation: Department of Microbiology, Research Institute for Tropical Medicine, Metro Manila, Philippines.)
JournalThe Southeast Asian journal of tropical medicine and public health (Southeast Asian J Trop Med Public Health) Vol. 21 Issue 2 Pg. 207-13 (Jun 1990) ISSN: 0125-1562 [Print] THAILAND
PMID2237588 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Age Factors
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • Dysentery, Bacillary (drug therapy, epidemiology)
  • Humans
  • Incidence
  • Infant
  • Microbial Sensitivity Tests
  • Philippines (epidemiology)
  • Prevalence
  • Serotyping
  • Shigella (classification, drug effects)
  • Urban Population

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD